PCV61 COST EFFECTIVENESS OF RIVAROXABAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS FOR TTR AND CHADS2 SCORE IN TURKEY
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.786
https://www.valueinhealthjournal.com/article/S1098-3015(19)33164-X/fulltext
Title :
PCV61 COST EFFECTIVENESS OF RIVAROXABAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS FOR TTR AND CHADS2 SCORE IN TURKEY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33164-X&doi=10.1016/j.jval.2019.09.786
First page :
Section Title :
Open access? :
No
Section Order :
10687